NewcelX Ltd (NCEL)

• Market cap: $9.75M
• 1 day: -14.4%
• 5 days: -17.37%
• 1 month: -42.16%
• 3 months: -91.27%
• 6 months: -92.62%
• Year to date: -90.18%
• 1 year: -92.13%
• 5 years: -99.81%
• 10 years: -99.81%
• Sector: Healthcare
• Industry: Biotechnology

About: NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.

Employees: 11